Source: FinanzNachrichten

Hua Medicine: Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC

SHANGHAI, Nov 30, 2024 - (ACN Newswire) - Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by whi...

Read full article »
Annual Revenue
$100K-5.0M
Employees
100-250
Li Chen's photo - President & CEO of Hua Medicine

President & CEO

Li Chen

CEO Approval Rating

90/100

Read more